Mounjaro: Uses, Dosing, Side Effects & Cost

Mounjaro is the brand name for tirzepatide, a once-weekly injection from Eli Lilly that is FDA-approved to treat type 2 diabetes. It is a dual GLP-1 and GIP receptor agonist, meaning it activates two gut-hormone pathways at once, which is the leading explanation for why it tends to lower blood sugar and body weight more than older single-hormone drugs. Many people take Mounjaro off-label for weight loss, though the FDA-approved weight version of the same molecule is sold under a different name, Zepbound.

This page is a plain-language hub. It gives you the big picture on Mounjaro, then points you to deeper articles on each topic so you can go as far as you want. Nothing here is medical advice, and only a licensed clinician can decide whether Mounjaro is right for you.

Mounjaro quick facts

Active ingredient	Tirzepatide
Drug class	Dual GLP-1 / GIP receptor agonist
Maker	Eli Lilly
How taken	Once-weekly subcutaneous injection
FDA-approved use	Type 2 diabetes
Doses	2.5, 5, 7.5, 10, 12.5, 15 mg weekly
List price / month	Roughly $1,069 before discounts
Weight-loss twin	Zepbound (same drug, tirzepatide)

How Mounjaro works

Most well-known injections in this family copy a single gut hormone called GLP-1. Mounjaro is different because it activates two receptors, GLP-1 and GIP, at the same time. In practice that means it helps the body release insulin when blood sugar is high, slows how fast the stomach empties, and reduces appetite so you feel full sooner and stay full longer. If you want the biology explained step by step, read our guide to how tirzepatide works.

Mounjaro dosing and how you start

Mounjaro is always started low and raised slowly to give your gut time to adjust. You begin at a 2.5 mg starter dose for four weeks, then move to 5 mg. From there the dose can rise in 2.5 mg steps, spaced at least four weeks apart, up to a maximum of 15 mg once weekly. The usual maintenance doses are 5, 10, or 15 mg. The starter dose is not meant to be your treatment dose; it exists only to reduce early nausea. Our full Mounjaro dosage guide walks through the whole schedule and what to do if you miss a week.

Mounjaro side effects

The most common side effects are gastrointestinal: nausea, diarrhea, vomiting, and constipation. These tend to be worst in the first weeks and each time the dose goes up, then ease as your body adapts. Mounjaro also carries a boxed warning about thyroid C-cell tumors seen in animal studies, so it is not used by people with certain thyroid or endocrine cancer histories. For the full list and how to manage each one, see Mounjaro side effects, and if you want to know when symptoms usually peak and fade, the GLP-1 side effects timeline lays it out week by week. A practical companion piece covers managing nausea on GLP-1 medication.

Mounjaro for weight loss

Even though Mounjaro is approved for diabetes, its effect on weight is striking. In the SURMOUNT-1 obesity trial, people on the 15 mg dose lost about 20.9% of their total body weight on average, more than trials of semaglutide have shown. That is why so many clinicians prescribe it off-label for weight, and why Lilly brought the identical molecule to market as Zepbound specifically for weight management. If diabetes is not part of your picture, read Mounjaro for weight loss without diabetes to understand what that path looks like. One important caveat: weight is often partly regained if the drug is stopped, because the appetite changes fade once it leaves your system.

Mounjaro versus other options

Choosing between injections is one of the most common questions people bring to their doctor. The comparison that matters most for the same molecule is Mounjaro vs Zepbound, since they are both tirzepatide with different labels and pricing. Against single-hormone GLP-1 drugs, see Ozempic vs Mounjaro and Mounjaro vs Wegovy. If you are moving up from an older weekly shot, Trulicity vs Mounjaro covers that switch. And to compare the underlying molecules rather than the brands, read semaglutide vs tirzepatide.

Mounjaro cost

Price is often the deciding factor. The list price is roughly $1,069 a month before any discounts, though what you actually pay depends heavily on insurance, savings cards, and whether you qualify for manufacturer help. Because Mounjaro and Zepbound share a molecule but not a price, it is worth comparing both. Our breakdown of Zepbound and Mounjaro cost without insurance shows the realistic out-of-pocket numbers and where the savings actually come from.

Living with Mounjaro day to day

Once you are on a steady dose, the practical questions become about ordinary life. Slowed digestion changes how alcohol feels, so it helps to read about GLP-1 medication and alcohol before a night out. Keeping an injection cool and on schedule while away from home is its own small project, which is why we wrote a guide to traveling with GLP-1 medication. These living-with-it topics are shared across the whole drug family, so they apply whether you are on Mounjaro, Zepbound, or a semaglutide product. Small habits make a big difference here: eating smaller portions more slowly, staying hydrated, and keeping meals lower in fat all tend to soften the digestive side effects that Mounjaro can cause, especially in the early weeks.

Is Mounjaro right for you?

Mounjaro is a powerful tool, not a shortcut. It works best alongside changes to how you eat and move, and it is prescribed and monitored by a clinician who weighs your medical history, your goals, and the cost. If you have type 2 diabetes it may be an on-label option; if your goal is purely weight loss, your clinician may point you toward Zepbound instead. The right answer is a conversation with a professional, informed by the details in the linked articles above. Come to that conversation with your questions ready, from cost and coverage to how long you might stay on treatment, so you and your clinician can build a plan that fits your life rather than a one-size-fits-all script.